AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2025
Nov 26, 2025
30826_dirs_2025-11-26_700a7f70-5ff7-4320-8874-ee2eb250bcbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2025-11-25
Reporting Person: Loeillot Olivier (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | Common Stock | S | 7041 | $170.00 | Disposed | 35898 | Direct |
Footnotes
F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 12, 2024.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23